Johnson Marvin 4
4 · MARINUS PHARMACEUTICALS, INC. · Filed Apr 19, 2023
Insider Transaction Report
Form 4
Johnson Marvin
Director
Transactions
- Award
Common Stock
2023-04-17+7,200→ 7,200 total - Award
Stock Option (Right to Buy)
2023-04-17+32,400→ 32,400 totalExercise: $8.01Exp: 2033-04-17→ Common Stock (32,400 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units (RSUs). The RSUs will vest in three equal annual installments, with the first installment vesting on April 17, 2024, the second installment vesting on April 17, 2025 and the third installment vesting on April 17, 2026, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
- [F2]The option vests and becomes exercisable in 36 equal monthly installments beginning on May 17, 2023, subject to the reporting person's continued service with the Issuer.